Array Biopharma shareholder Kopp Investment reports 6.2% stake

By Lisa Kerner

Charlotte, N.C., Sept. 21 - A group of Array Biopharma, Inc. shareholders led by Kopp Investment Advisors, LLC had a 6.2% stake in the company following a series of buy and sell transactions between July 27 and Sept. 10, according to a schedule 13D/A filed on Monday with the Securities and Exchange Commission.

The investors bought a net 344,556 shares of Array's stock between May 26 and July 24 and reported a 5.2% ownership interest, a prior SEC filing said.

Kopp beneficially owns 2,971,726 shares of the Boulder, Colo.-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.